BE901489A - Procede de traitement de maladies cardiaques. - Google Patents

Procede de traitement de maladies cardiaques.

Info

Publication number
BE901489A
BE901489A BE0/214326A BE214326A BE901489A BE 901489 A BE901489 A BE 901489A BE 0/214326 A BE0/214326 A BE 0/214326A BE 214326 A BE214326 A BE 214326A BE 901489 A BE901489 A BE 901489A
Authority
BE
Belgium
Prior art keywords
quinolone
methyl
treatment
heart disease
equal
Prior art date
Application number
BE0/214326A
Other languages
English (en)
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848400905A external-priority patent/GB8400905D0/en
Priority claimed from GB848400906A external-priority patent/GB8400906D0/en
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of BE901489A publication Critical patent/BE901489A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Procédé de traitement de défaillances cardiaques chez les mammifères, caractérisé en ce qu'on administre une quinolone de la formule générale I dans laquelle n'est égal à O ou à 1, n'est égal à O, 1 ou 2 et R représente un atome d'hydrogène, un atome d'halogène, le radical méthyle ou trifluorométhyle. Le procédé préféré consiste à traiter les défaillances cardiaques chroniques d'un mammifère par l'administration orale d'une quinolone de la formule I. Les composés préférés sont la 7-fluoro-1-méthyl-3-méthylsulphinyl-4-quinolone et la 1-méthyl-3-méthylsul-phonylméthyl-4-quinolone.
BE0/214326A 1984-01-13 1985-01-14 Procede de traitement de maladies cardiaques. BE901489A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848400905A GB8400905D0 (en) 1984-01-13 1984-01-13 Therapeutic agents
GB848400906A GB8400906D0 (en) 1984-01-13 1984-01-13 Therapeutic agents

Publications (1)

Publication Number Publication Date
BE901489A true BE901489A (fr) 1985-07-15

Family

ID=26287186

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/214326A BE901489A (fr) 1984-01-13 1985-01-14 Procede de traitement de maladies cardiaques.

Country Status (5)

Country Link
US (1) US4552884A (fr)
EP (1) EP0149519B1 (fr)
BE (1) BE901489A (fr)
DE (2) DE3578374D1 (fr)
IT (1) IT1221010B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8515209D0 (en) * 1985-06-15 1985-07-17 Boots Co Plc Therapeutic agents
GB8627698D0 (en) * 1986-11-20 1986-12-17 Boots Co Plc Therapeutic agents
GB8726950D0 (en) * 1987-11-18 1987-12-23 Boots Co Plc Chemical process
GB8804016D0 (en) * 1988-02-22 1988-03-23 Boots Co Plc Therapeutic agents
EP0651640A1 (fr) * 1992-07-21 1995-05-10 Knoll AG Utilisation de 7-fluoro-1-methyl-3-methylsulphinyl-4-quinolone dans le traitement de l'angine de poitrine
TW593317B (en) * 1993-06-21 2004-06-21 Janssen Pharmaceutica Nv Positive cardiac inotropic and lusitropic pyrroloquinolinone derivatives
US8697674B2 (en) * 2004-12-29 2014-04-15 Naturon, Inc. Xanthurenic acid derivative pharmaceutical compositions and methods related thereto

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ193167A (en) * 1979-03-27 1984-08-24 Boots Co Plc Quinoline derivatives and pharmaceutical compositions
GB2085441B (en) * 1980-09-26 1984-10-17 Boots The Co Ltd Therapeutic agents
IE51542B1 (en) * 1980-09-26 1987-01-07 Boots Co Ltd Therapeutic agents

Also Published As

Publication number Publication date
DE3500756A1 (de) 1985-07-25
EP0149519A2 (fr) 1985-07-24
EP0149519A3 (en) 1987-09-23
US4552884A (en) 1985-11-12
DE3578374D1 (de) 1990-08-02
IT1221010B (it) 1990-06-21
EP0149519B1 (fr) 1990-06-27
IT8519042A0 (it) 1985-01-08

Similar Documents

Publication Publication Date Title
BE902213A (fr) Composes de phenethanolamine.
NO152902C (no) Analogifremgangsmaae for fremstilling av terapeutisk virksomme 1-alkyl-2-aminotetralinderivater
DK282488A (da) Farmaceutiske praeparater, deri indgaaende phenylalkylaminger eller salte deraf og forbindelsernes fremstilling
ES2039354T3 (es) Tratamiento transdermico del dolor y de la inflamacion con acidos 2-amino-3-aroilbencenaceticos, sales y esteres.
BE903183A (fr) Nouveaux derives du benzonorbornene, leurs procedes de preparation et composition medicamenteuse et cosmetique les contenant
BE901210A (fr) Nouveaux retinoides.
FR2506306A1 (fr) Nouveaux derives de l'amidinopiperidine, leur procede de preparation et leur application en therapeutique
SE8500996D0 (sv) Method of treatment
FR2439194A1 (fr) Derives de la dibenzothiepine, leur procede de preparation et leur application therapeutique
FR2367750A1 (fr) Acid
ATE26273T1 (de) 3-indolcarboxamid-verbindungen.
IL79910A (en) 5,7-dihydro-6-(thi)oxopyrrolo(2,3-f)benzimidazole,-benzothiazole and-benzoxazoles,6-imines thereof,their preparation and pharmaceutical compositions containing them
FR2403336A1 (fr) Derives de 3,4-dihydrocarbostyrile, leur procede de preparation et leur utilisation pour le traitement des troubles cardiaques
FR2393579A1 (fr) Agent antiviral et son application au traitement des affections virales
KR940010999A (ko) 이미다졸-1-일 화합물을 포함하는 새로운 약제
FR2375245A1 (fr) Acides carboxyphosphoniques utilisables pour le traitement d'eaux
FR2397425A1 (fr) Nouveaux derives de la daunorubicine, leur preparation et les compositions qui les contiennent
PT77666A (fr) Procede de preparation de nouveaux derives de la nitrosouree
FR2422667A1 (fr) Derives de 7a-methoxycephalosporine, leur procede de preparation et leur application en therapeutique
KR880001596A (ko) 디하이드로피리딘 화합물-함유 뇌기능이상 치료제
FR2398057A1 (fr) Derives halogenomethyles du tryptophanne, leur preparation et leur utilisation dans le traitement des affections du systeme nerveux
IE790157L (en) Therapeutic agents
FR2401922A1 (fr) Picolylamides d'acides 4-hydroxy-isophtaliques substitues, leur preparation et leurs utilisations therapeutiques
FR2442827A1 (fr) Nouveaux acides oxy-cyclohexylacetiques substitues, leur procede de preparation et leur application en therapeutique
BE902259A (fr) Nouveaux derives d'apovincaminol, procede pour leur preparation et compositions pharmaceutiques les contenant.

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: THE BOOTS CY P.L.C.

Effective date: 19970131